Melbourne researchers believe that understanding how kangaroos repair their DNA could be the key to preventing skin cancer in the future.
02/12/2009
MOLECULAR therapeutics targeting protein kinases have proven successful in treating some cancer patients, especially those with pathologies derived by oncogenic forms of tyrosine kinases.
09/03/2009
ALCHEMIA has entered into a drug discovery agreement with SDP Technology, giving SDP the exclusive rights to develop anti-cancer drugs targeting the enzyme sphingosine kinase 1 using Alchemia’s VAST chemistry.
20/03/2009
CYTOPIA has filed an Investigational New Drug Application with the US Food and Drug Administration for its orally active JAK2 inhibitor CYT387.
24/06/2009
OUR DNA is not as defenceless as once thought, with researchers at the University of Michigan identifying a key protein which plays not one, but two critical roles in affecting the development of cancer.
14/01/2009
AUSTRALIAN Professor Elizabeth Blackburn has been awarded the Nobel Prize for Physiology or Medicine, along with Carol Greider and Jack Szostak, for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase.
06/10/2009
THE Blanchette Rockefeller Neurosciences Institute (BRNI) has received a green light from the FDA to enter Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
24/04/2009
PORVAIR Sciences has announced the launch of its range of high quality Polymerase Chain Reaction (PCR) plates.
29/05/2009
A DRUG developed in the 1970’s has found its way back into modern medicine, performing as a chemoprevention agent in animal models.
20/01/2009